XTL BIOPHARMACEUTICALS LTD. (XTLB) Operating income 2015–2024
XTL BIOPHARMACEUTICALS LTD. (XTLB) annual operating income history from SEC filings — each fiscal year as reported.
-$2.2MFY2024 · since FY2015: -$3.6M → -$2.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$2.2M | -183.9% |
| FY2023 | -$765,000 | +13.1% |
| FY2022 | -$880,000 | +14.6% |
| FY2021 | -$1.0M | -8.8% |
| FY2020 | -$948,000 | -12.6% |
| FY2019 | -$842,000 | -6.2% |
| FY2018 | -$793,000 | +36.4% |
| FY2017 | -$1.2M | +51.3% |
| FY2016 | -$2.6M | +29.1% |
| FY2015 | -$3.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice